Table of Contents Chapter 1 Overview of Molecular Diagnostics 1.1 Definition of Molecular Diagnostics in This Report 1.2 Commercial Types of Molecular Diagnostics 1.2.1 Infectious Disease 1.2.2 Oncology 1.2.3 Genetics 1.2.4 Microbiology 1.3 Downstream Application of Molecular Diagnostics 1.3.1 Hospital 1.3.2 Laboratories 1.4 Development History of Molecular Diagnostics 1.5 Market Status and Trend of Molecular Diagnostics 2013-2023 1.5.1 Europe Molecular Diagnostics Market Status and Trend 2013-2023 1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023 Chapter 2 Europe Market Status and Forecast by Regions 2.1 Market Status of Molecular Diagnostics in Europe 2013-2017 2.2 Consumption Market of Molecular Diagnostics in Europe by Regions 2.2.1 Consumption Volume of Molecular Diagnostics in Europe by Regions 2.2.2 Revenue of Molecular Diagnostics in Europe by Regions 2.3 Market Analysis of Molecular Diagnostics in Europe by Regions 2.3.1 Market Analysis of Molecular Diagnostics in Germany 2013-2017 2.3.2 Market Analysis of Molecular Diagnostics in United Kingdom 2013-2017 2.3.3 Market Analysis of Molecular Diagnostics in France 2013-2017 2.3.4 Market Analysis of Molecular Diagnostics in Italy 2013-2017 2.3.5 Market Analysis of Molecular Diagnostics in Spain 2013-2017 2.3.6 Market Analysis of Molecular Diagnostics in Benelux 2013-2017 2.3.7 Market Analysis of Molecular Diagnostics in Russia 2013-2017 2.4 Market Development Forecast of Molecular Diagnostics in Europe 2018-2023 2.4.1 Market Development Forecast of Molecular Diagnostics in Europe 2018-2023 2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023 Chapter 3 Europe Market Status and Forecast by Types 3.1 Whole Europe Market Status by Types 3.1.1 Consumption Volume of Molecular Diagnostics in Europe by Types 3.1.2 Revenue of Molecular Diagnostics in Europe by Types 3.2 Europe Market Status by Types in Major Countries 3.2.1 Market Status by Types in Germany 3.2.2 Market Status by Types in United Kingdom 3.2.3 Market Status by Types in France 3.2.4 Market Status by Types in Italy 3.2.5 Market Status by Types in Spain 3.2.6 Market Status by Types in Benelux 3.2.7 Market Status by Types in Russia 3.3 Market Forecast of Molecular Diagnostics in Europe by Types Chapter 4 Europe Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Molecular Diagnostics in Europe by Downstream Industry 4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries 4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in Germany 4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in United Kingdom 4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in France 4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in Italy 4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in Spain 4.2.6 Demand Volume of Molecular Diagnostics by Downstream Industry in Benelux 4.2.7 Demand Volume of Molecular Diagnostics by Downstream Industry in Russia 4.3 Market Forecast of Molecular Diagnostics in Europe by Downstream Industry Chapter 5 Market Driving Factor Analysis of Molecular Diagnostics 5.1 Europe Economy Situation and Trend Overview 5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview Chapter 6 Molecular Diagnostics Market Competition Status by Major Players in Europe 6.1 Sales Volume of Molecular Diagnostics in Europe by Major Players 6.2 Revenue of Molecular Diagnostics in Europe by Major Players 6.3 Basic Information of Molecular Diagnostics by Major Players 6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players 6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Molecular Diagnostics Major Manufacturers Introduction and Market Data 7.1 Roche Diagnostics 7.1.1 Company profile 7.1.2 Representative Molecular Diagnostics Product 7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 7.2 QIAGEN N.V. 7.2.1 Company profile 7.2.2 Representative Molecular Diagnostics Product 7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V. 7.3 Hologic Inc 7.3.1 Company profile 7.3.2 Representative Molecular Diagnostics Product 7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc 7.4 Grifols 7.4.1 Company profile 7.4.2 Representative Molecular Diagnostics Product 7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols 7.5 Abbott Laboratories 7.5.1 Company profile 7.5.2 Representative Molecular Diagnostics Product 7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 7.6 Siemens Healthcare 7.6.1 Company profile 7.6.2 Representative Molecular Diagnostics Product 7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare 7.7 Becton, Dickinson 7.7.1 Company profile 7.7.2 Representative Molecular Diagnostics Product 7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson 7.8 Beckman Coulter 7.8.1 Company profile 7.8.2 Representative Molecular Diagnostics Product 7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter 7.9 bioMérieux SA 7.9.1 Company profile 7.9.2 Representative Molecular Diagnostics Product 7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioMérieux SA 7.10 Cepheid 7.10.1 Company profile 7.10.2 Representative Molecular Diagnostics Product 7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid Chapter 8 Upstream and Downstream Market Analysis of Molecular Diagnostics 8.1 Industry Chain of Molecular Diagnostics 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Molecular Diagnostics 9.1 Cost Structure Analysis of Molecular Diagnostics 9.2 Raw Materials Cost Analysis of Molecular Diagnostics 9.3 Labor Cost Analysis of Molecular Diagnostics 9.4 Manufacturing Expenses Analysis of Molecular Diagnostics Chapter 10 Marketing Status Analysis of Molecular Diagnostics 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Infectious Disease Table Advantage and Disadvantage of Oncology Table Advantage and Disadvantage of Genetics Table Advantage and Disadvantage of Microbiology Table Consumption Volume of Molecular Diagnostics in Europe by Regions 2013-2017 Table Revenue of Molecular Diagnostics in Europe by Regions 2013-2017 Table Consumption Volume of Molecular Diagnostics in Europe by Regions 2018-2023 Table Revenue of Molecular Diagnostics in Europe by Regions 2018-2023 Table Consumption Volume of Molecular Diagnostics in Europe by Types 2013-2017 Table Revenue of Molecular Diagnostics in Europe by Types 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Germany 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in United Kingdom 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in France 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Italy 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Spain 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Benelux 2013-2017 Table Consumption Volume of Molecular Diagnostics by Types in Russia 2013-2017 Table Consumption Volume Forecast of Molecular Diagnostics in Europe by Types 2018-2023 Table Revenue Forecast of Molecular Diagnostics in Europe by Types 2018-2023 Table Demand Volume of Molecular Diagnostics in Europe by Downstream Industry 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Germany 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in United Kingdom 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in France 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Italy 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Spain 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Benelux 2013-2017 Table Demand Volume of Molecular Diagnostics by Downstream Industry in Russia 2013-2017 Table Demand Volume Forecast of Molecular Diagnostics in Europe by Downstream Industry 2018-2023 Table Sales Volume of Molecular Diagnostics in Europe by Major Players 2013-2017 Table Revenue of Molecular Diagnostics in Europe by Major Players 2013-2017 Table Headquarters Location and Established Time of Molecular Diagnostics Major Players Table Employees and Revenue Level of Molecular Diagnostics Major Players Table Representative Molecular Diagnostics Product One of Roche Diagnostics Table Representative Molecular Diagnostics Product Two of Roche Diagnostics Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017 Table Representative Molecular Diagnostics Product One of QIAGEN N.V. Table Representative Molecular Diagnostics Product Two of QIAGEN N.V. Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V. 2013-2017 Table Representative Molecular Diagnostics Product One of Hologic Inc Table Representative Molecular Diagnostics Product Two of Hologic Inc Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc 2013-2017 Table Representative Molecular Diagnostics Product One of Grifols Table Representative Molecular Diagnostics Product Two of Grifols Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols 2013-2017 Table Representative Molecular Diagnostics Product One of Abbott Laboratories Table Representative Molecular Diagnostics Product Two of Abbott Laboratories Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Molecular Diagnostics Product One of Siemens Healthcare Table Representative Molecular Diagnostics Product Two of Siemens Healthcare Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare 2013-2017 Table Representative Molecular Diagnostics Product One of Becton, Dickinson Table Representative Molecular Diagnostics Product Two of Becton, Dickinson Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson 2013-2017 Table Representative Molecular Diagnostics Product One of Beckman Coulter Table Representative Molecular Diagnostics Product Two of Beckman Coulter Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter 2013-2017 Table Representative Molecular Diagnostics Product One of bioMérieux SA Table Representative Molecular Diagnostics Product Two of bioMérieux SA Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioMérieux SA 2013-2017 Table Representative Molecular Diagnostics Product One of Cepheid Table Representative Molecular Diagnostics Product Two of Cepheid Table Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017